Clinical Trial Update: Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing irinotecan to a combination chemotherapy regimen in patients with advanced colorectal cancer. The study, including mucinous a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Combination chemotherapy (unspecified)
• Irinotecan (Camptosar) (Irinotecan)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum | Phase 3 | Status: COMPLETED